Tempus AI, Inc. (NASDAQ:TEM) Receives Average Rating of “Moderate Buy” from Analysts

Tempus AI, Inc. (NASDAQ:TEM) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $45.56.

Several equities research analysts have recently weighed in on the company. Bank of America started coverage on Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $41.00 price objective for the company. Stifel Nicolaus began coverage on Tempus AI in a report on Tuesday, July 9th. They set a “buy” rating and a $45.00 price target on the stock. Piper Sandler assumed coverage on Tempus AI in a research note on Monday, August 12th. They set a “neutral” rating and a $40.00 price objective for the company. JPMorgan Chase & Co. boosted their target price on Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Finally, Morgan Stanley began coverage on Tempus AI in a report on Tuesday, July 9th. They set an “overweight” rating and a $44.00 price target for the company.

Tempus AI Stock Up 8.7 %

NASDAQ:TEM opened at $54.43 on Friday. Tempus AI has a 1 year low of $22.89 and a 1 year high of $77.00. The business’s 50-day simple moving average is $48.37.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing analysts’ consensus estimates of ($4.41) by ($2.36). The company had revenue of $165.97 million for the quarter, compared to analysts’ expectations of $159.10 million. As a group, research analysts forecast that Tempus AI will post -6.51 earnings per share for the current year.

Institutional Investors Weigh In On Tempus AI

A number of hedge funds and other institutional investors have recently modified their holdings of TEM. Sandia Investment Management LP purchased a new stake in Tempus AI in the second quarter valued at approximately $136,000. Northwestern University acquired a new position in Tempus AI in the second quarter valued at $491,000. Squarepoint Ops LLC purchased a new stake in Tempus AI during the second quarter valued at about $633,000. WINTON GROUP Ltd acquired a new stake in Tempus AI during the second quarter worth about $634,000. Finally, Scientech Research LLC purchased a new position in shares of Tempus AI in the 2nd quarter worth about $756,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.